Abstract
The aim of the present study was to investigate the role of anti-inflammation for MSCs transplantation in rat models of myocardial infarction. Rats with AMI induced by occlusion of the left coronary artery were randomized to MSCs transplantation group, MI group and sham operated group. The effects of MSCs transplantation on cardiac inflammation and left ventricular remodeling in non-infarcted zone were observed after 4 weeks of MI. We found that MSC transplantation (1) decreased protein production and gene expression of inflammation cytokines TNF-α, IL-1β and IL-6, (2) inhibited deposition of type I and III collagen, as well as gene and protein expression of MMP-1 and TIMP-1, (3) attenuated LV cavitary dilation and transmural infarct thinning, thus prevent myocardial remodeling after myocardial infarction, and (4) increased EF, FS, LVESP and dp/dtmax (P < 0.01), decreased LVDd, LVEDV, LVEDP (P < 0.05). Anti-inflammation role for MSCs transplantation might partly account for the cardiac protective effect in ischemic heart disease.
Similar content being viewed by others
References
Li, R. K., D. A. Mickle, R. D. Weisel, M. K. Mohabeer, J. Zhang, V. Rao, et al. 1997. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 96(9 Suppl):II-179–186; discussion 186–187.
Scorsin, M., A. Hagege, J. T. Vilquin, M. Fiszman, F. Marotte, J. L. Samuel, et al. 2000. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J. Thorac. Cardiovasc. Surg. 119:1169–1175.
Min, J. Y., Y. Yang, K. L. Converso, L. Liu, Q. Huang, and J. P. Morgan, et al. 2002. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92:288–296.
Min, J. Y., Y. Yang, M. F. Sullivan, Q. Ke, K. L. Converso, Y. Chen, et al. 2003. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg. 125:361–369.
Taylor, D. A., B. Z. Atkins, P. Hungspreugs, T. R. Jones, M. C. Reedy, K. A. Hutcheson, et al. 1998. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 4:929–933.
Menasche, P., A. A. Hagege, M. Scorsin, B. Pouzet, M. Desnos, D. Duboc, et al. 2001. Myoblast transplantation for heart failure. Lancet 357:279–280.
Jiang, Y., B. N. Jahagirdar, R. L. Reinhardt, R. E. Schwartz, C. D. Keene, X. R. Ortiz-Gonzalez, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41–49.
Pittenger, M. F., and B. J. Martin. 2004. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95:9.
Barry, F. P., and J. M. Murphy. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell. Biol. 36:568.
Toma, C., M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler. 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93–98.
Shake, J. G., P. J. Gruber, W. A. Baumgartner, G. Senechal, J. Meyers, J. M. Redmond, et al. 2002. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73:1919–1926.
Mangi, A. A., N. Noiseux, D. Kong, H. He, M. Rezvani, and J. S. Ingwall, et al. 2003. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9:1201–1995.
Makino, S., K. Fukuda, S. Miyoshi, F. Konishi, H. Kodama, J. Pan, et al. 1999. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697–705.
Toma, C., M. F. Pittenger, K. S. Cahill, B. J. Byrne, and P. D. Kessler. 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93–98.
Uemura, R., M. Xu, N. Ahmad, and M. Ashraf. 2006. Bone Marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ. Res. 98:1414–1421.
Hou, M., K.-M. Yang, H. Zhang, W.-Q. Zhu, F.-J. Duan, H. Wang, et al. 2007. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int. J. Cardiol. 115:220–228.
Nygren, J. M., S. Jovinge, M. Breitbach, P. Sawen, W. Roll, J. Hescheler, et al. 2004. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494–501.
Zhang, S., D. Wang, Z. Estrov, S. Raj, J. T. Willerson, and E. T. Yeh. 2004. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110:3803–3807.
Andrade, J., J. T. Lam, M. Zamora, C. Huang, D. Franco, N. Sevilla, et al. 2005. Predominant fusion of bone marrow-derived cardiomyocytes. Cardiovasc. Res. 68:387–393.
Ohnishi, S., B. Yanagawa, K. Tanaka, Y. Miyahara, H. Obata, M. Kataoka, et al. 2007. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J. Mol. Cell Cardiol. 42:88–97.
DiNicola, M., C. Carlo-Stella, M. Magni, M. Milanesi, P. D. Longoni, P. Matteucci, et al. 2002. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843.
Tse, W. T., J. D. Pendleton, W. M. Beyer, M. C. Egalka, and E. C. Guinan. 2003. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389–397.
Ono, K., A. Matsumori, T. Shioi, Y. Furukawa, S. Sasayama. 1998. Cytokine gene expression after myocardial infarction in rat hearts. Possible implication in left ventricular remodeling. Circulation 98:149–156.
Sugano, M., K. Tsuchida, T. Hata, and N. Makino. 2004. In vivo transfer of soluble TNF-α receptor 1 gene improves cardiac function and reduces infarct size after myocardial infarction in rats. FASEB J. 18:911–913.
Berry, M. F., J. Woo, T. J. Pirolli, L. T. Bish, M. A. Moise, J. Burdick, et al. 2004. Administration of tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. J. Heart Lung Transplant. 23:1061–1068.
Siwik, D. A., D. Chang, and W. S. Colucci. 2000. Interleukin-1beta and tumor necrosis factor alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ. Res. 86:1259–1265.
Peterson, J. T., H. Li, L. Dillon, J. W. Bryant. 2000. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46:307–315.
Lutgens, E., M. J. Daemen, E. D. de Muinck, J. Debets, P. Leenders, and J. F. Smits. 1999. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc. Res. 41:586–593.
Van Kerckhoven, R., E. A. Kalkman, P. R. Saxena, and R. G. Schoemaker. 2000. Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts. Cardiovasc. Res. 46:316–323.
Xu, X., Z. Xu, Y. Xu, and G. Cui. 2005. Selective down-regulation of extracellular matrix gene expression by bone marrow derived stem cell transplantation into infarcted myocardium. Circ. J. 69:1275–1283.
Jugdutt, B. I. 2003. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108:1043–1395.
Acknowledgements
We thank Jun Cai (Department of Cardiology, Chaoyang Hospital, Peking), Xi Wang, Ping Hu, Yanhong Tang and Hong-gang Chu (Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan, China) for great assistance. This project was supported by department of health of Hubei province (JX3B48), department of education of Hubei province for excellent youth science and tech group(No T200606), department of technology of Hubei province (2005AA301C38-2) and Xianning college (KY0565).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, J., Lin, Gs., Bao, Cy. et al. Anti-Inflammation Role for Mesenchymal Stem Cells Transplantation in Myocardial Infarction. Inflammation 30, 97–104 (2007). https://doi.org/10.1007/s10753-007-9025-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-007-9025-3